Lexeo Therapeutics, Inc.·4

May 20, 5:00 PM ET

Robertson Jenny 4

4 · Lexeo Therapeutics, Inc. · Filed May 20, 2025

Insider Transaction Report

Form 4
Period: 2025-05-16
Robertson Jenny
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2025-05-16$2.77/sh521$1,44563,098 total
Footnotes (2)
  • [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
  • [F2]Includes 52,577 restricted stock units.

Documents

1 file
  • 4
    form4-05202025_050504.xmlPrimary